NEW YORK--(BUSINESS WIRE)--Amphion Innovations plc, a builder of companies in life sciences and technology, today announces that one of its partner companies, Motif Biosciences, Inc, a population genetics company in the Arabian Gulf Region, has raised $1 million in a Series C financing. Amphion, which owns 42% of Motif, has invested $400,000 as part of this round. Motif is in the process of raising up to $3 million in capital and anticipates that it will conclude additional financing rounds in the coming months.
